Abstract |
Aim: Our main objectives were to compare the effects of Rejuveinix (RJX), dexamethasone (DEX) and their combination on the severity of sepsis and survival outcome in an animal model of fatal sepsis. Methods: We used the LPS plus D- galactosamine mouse model of sepsis to compare the anti-inflammatory activities of RJX, dexamethasone and a combination of RJX plus DEX. Additionally, we examined the clinical feasibility and tolerability of combining RJX with DEX in COVID-19 patients in a clinical phase I study. Data were analyzed using standard methods. Results & conclusion: RJX exhibited potent anti-inflammatory activity in the murine sepsis model. The combination of RJX plus DEX was more effective than either agent alone, decreased the inflammatory cytokine responses and associated organ damage, and improved the survival outcome in mice. In the phase I clinical study, RJX plus DEX was well tolerated by COVID-19 patients.
|
Authors | Fatih M Uckun, Muhammad Saeed, Mustafa Awili, Ibrahim H Ozercan, Sanjive Qazi, Cynthia Lee, Adeel Shibli, Alan W Skolnick, Alonso Prusmack, Joseph Varon, Cesar Ip Barrera, Cemal Orhan, Michael Volk, Kazim Sahin |
Journal | Future microbiology
(Future Microbiol)
Vol. 17
Pg. 1217-1229
(Oct 2022)
ISSN: 1746-0921 [Electronic] England |
PMID | 36052743
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Drug Combinations
- ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination
- Pantothenic Acid
- Niacinamide
- Magnesium Sulfate
- Dexamethasone
- Pyridoxine
- Ascorbic Acid
- Riboflavin
- Thiamine
|
Topics |
- Animals
- Anti-Inflammatory Agents
(therapeutic use)
- Ascorbic Acid
- Dexamethasone
(therapeutic use)
- Disease Models, Animal
- Drug Combinations
- Magnesium Sulfate
- Mice
- Niacinamide
- Pantothenic Acid
- Pyridoxine
- Riboflavin
- Sepsis
(drug therapy)
- Thiamine
- COVID-19 Drug Treatment
|